AnaptysBio, Inc.
ANAB
$20.70
$0.090.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 33.69% | 29.59% | -6.20% | -4.09% | -13.14% |
| Total Depreciation and Amortization | 0.84% | 0.17% | -1.65% | 0.17% | 2.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 10.70% | 31.31% | 18.84% | 35.96% | 7.25% |
| Change in Net Operating Assets | -6,191.67% | -87.06% | 217.85% | -178.58% | 70.49% |
| Cash from Operations | -560.77% | 52.68% | 42.76% | -8.45% | 5.83% |
| Capital Expenditure | -651.43% | -6.06% | -22.22% | 90.36% | -72.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -149.67% | 2,534.83% | -103.51% | 38.79% | 60.59% |
| Cash from Investing | -150.15% | 2,500.49% | -103.56% | 39.53% | 60.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.44% | 9,960.98% | 20.72% | 207.20% | 65.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 200.74% | -166.65% | 383.24% | -166.35% | -67.79% |
| Cash from Financing | -61.30% | 70.04% | 407.27% | -164.26% | -67.94% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -157.20% | 560.71% | 2.23% | 83.35% | 208.52% |